GlaxoSmithKline CEO: “We had to absorb a number of hits” Mon, 16 Feb 2004 Antidepressant drug safety issues are beginning to have a financial impact. Dow Jones reports: “GlaxoSmithKline PLC said its net income fell 6% in the fourth quarter, hurt by previously announced legal costs related to its anti-inflammatory…
“The scariest thing is that nobody knows” risks of depression drugs for children Mon, 10 May 2004 Forest Laboratories, manufacturer of the antidepressant, Celexa / Lexapro, is the latest manufacturer to issue warnings (April 2004) about the possibility that “patients with major depressive disorder, both adult and pediatric, may experience…
Bill Moyers: the Real Show…Congressional hearing was abruptly cancelled Tue, 27 Jul 2004 Congressman Greenwoods’ retirement statement indicates that he had negotiated his contract with Biotechnology Industry Org–a company that represents the very industry he was in the middle of investigating–on Tuesday. http://www.house.gov/greenwood/press_releases/2004/pr040722.html Tuesday was the precise day that Greenwood…
Dr. Loren Mosher, 1933 – 2004 Tue, 13 Jul 2004 We are deeply saddened by the death of AHRP board member, Loren Mosher, MD, a psychiatrist of integrity who never yielded to the pressures brought to bear by (in his words) “the unholy alliance” of the drug industry and industry-supported…
Former FDA Commissioner says FDA lost public trust Mon, 17 Oct 2005 The FDA’s failure to ensure drugs are properly tested in trials designed to detect serious adverse effects, and the agency’s failure to require follow-up post-marketing studies to be reasonably secure in the knowledge that no lethal drugs are unleashed on the public has…
DHHS Report: Contradicting itself on drug imports – OpEd Peter Rost Wed, 5 Jan 2005 Dr. Peter Rost, a Pfizer Vice-President of Marketing knows about the financial underpinnings of drug pricing. He has taken a consciencious public position (unsusual in that industry) because he believes the American public has a…
NYC Community Protest Rally: Child Abuse AIDS Experiments– Incarnation Center Saturday 3-26-05 Thu, 24 Mar 2005 Frustrated by the shroud of secrecy which protects institutions that violate ethical standards in medical research, community action groups are holding an emergency protest on Saturday, March 26 in New York City in front…
FDA Official Admits ‘Lapses’ on Vioxx – FDA Didn’t Heed Warnings on Dangers of MS Drug Wed, 2 Mar 2005 As the Senate committee on Health, Education, Labor and Pensions prepares for the second day hearing about FDA’s performance, one hopes that the committee will follow up Tuesday’s hearing with…
The Facts about Medicare “Wider Choices in Drug Benefits" Thu, June 16, 2005 The New York Times reports: “The expansion of Medicare to cover prescription drugs is President Bush’s most significant achievement in domestic policy. He plans to emphasize it at two events this week, on Thursday in Washington and…
Why We Need Whistleblowers–One-third US Scientists Admit Unethical Research Practices Sat, 11 Jun 2005 Although the major focus of these AHRP Infomails has been on the deplorable misconduct by the pharmaceutical industry and government health care agencies, whenever we pointed a flashlight at academia and biomedical scientists, we raised the…
Lilly to Add Suicide Warning to Strattera – Medicaid May shrink $5.5 Billion spending on Schizophrenia Drug Thu, 29 Sep 2005 Reuters reports that Eli Lilly is adding a Black Box suicide warning to the Strattera label. Strattera has been promoted as a “non stimulant” treatment for ADHD. Since ADHD…
SC Supreme Court To Hear Christopher Pittman Appeal Thu, 1 Sep 2005 This just in from Miracles Of Hope Network New York – Chicago – Paris – Hollywood – Washington DC – Atlanta – Las Vegas The South Carolina Supreme Court has by-passed the Court of Appeals and will hear…
